APOSTOLOS GAITANIDIS

Dr. APOSTOLOS GAITANIDIS

orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 December 2016 in Open Forum Infectious Diseases
Verified
Journal Article
Open access
PDF file
MAMichail Alevizakos
Michail Alevizakos
APOSTOLOS GAITANIDISAPOSTOLOS GAITANIDIS
APOSTOLOS GAITANIDIS
DNDimitrios Nasioudis
Dimitrios Nasioudis
KTKaterina Tori
Katerina Tori
MFMyrto Eleni Flokas
Myrto Eleni Flokas
Eleftherios MylonakisEleftherios Mylonakis
Eleftherios Mylonakis
Background: Vancomycin-resistant enterococci (VRE) cause severe infections among patients with malignancy, and these infections are usually preceded by gastrointestinal colonization. Methods: We searched the PubMed and EMBASE databases (up to May 26, 2016) to identify studies that reported data on VRE gastrointestinal colonization among patients with solid or hematologic malignancy. Results: Thirty-four studies, reporting data on 8391 patients with malignancy, were included in our analysis. The pooled prevalence of VRE colonization in this population was 20% (95% confidence interval [CI], 14%–26%). Among patients with hematologic malignancy, 24% (95% CI, 16%–34%) were colonized with VRE, whereas no studies reported data solely on patients with solid malignancy. Patients with acute leukemia were at higher risk for VRE colonization (risk ratio [RR] = 1.95; 95% CI, 1.17–3.26). Vancomycin use or hospitalization within 3 months were associated with increased colonization risk (RR = 1.92, 95% CI = 1.06–3.45 and RR = 4.68, 95% CI = 1.66–13.21, respectively). Among the different geographic regions, VRE colonization rate was 21% in North America (95% CI, 13%–31%), 20% in Europe (95% CI, 9%–34%), 23% in Asia (95% CI, 13%–38%), and 4% in Oceania (95% CI, 2%–6%). More importantly, colonized patients were 24.15 (95% CI, 10.27–56.79) times more likely to develop a bloodstream infection due to VRE than noncolonized patients. Conclusions: A substantial VRE colonization burden exists among patients with malignancy, and colonization greatly increases the risk for subsequent VRE bloodstream infection. Adherence to antimicrobial stewardship is needed, and a re-evaluation of the use of vancomycin as empiric therapy in this patient population may be warranted.

1 August 2018 in Clinical Breast Cancer
Verified
Journal Article
Closed access
APOSTOLOS GAITANIDISAPOSTOLOS GAITANIDIS
APOSTOLOS GAITANIDIS
MAMichail Alevizakos
Michail Alevizakos
CTChristos Tsalikidis
Christos Tsalikidis
ATAlexandra Tsaroucha
Alexandra Tsaroucha
CSConstantinos Simopoulos
Constantinos Simopoulos
MPMichail Pitiakoudis
Michail Pitiakoudis

1 June 2019 in Clinical Genitourinary Cancer
Verified
Journal Article
Closed access
MAMichail Alevizakos
Michail Alevizakos
APOSTOLOS GAITANIDISAPOSTOLOS GAITANIDIS
APOSTOLOS GAITANIDIS
DNDimitrios Nasioudis
Dimitrios Nasioudis
PMPavlos Msaouel
Pavlos Msaouel
LALeonard J. Appleman
Leonard J. Appleman

24 May 2022 in The Lancet Global Health
Verified
Journal Article
Open access
CSCatherine A Shaw
Catherine A Shaw
RPRiinu Pius
Riinu Pius
TDThomas M Drake
Thomas M Drake
LNLisa Norman
Lisa Norman
AAAdesoji O Ademuyiwa
Adesoji O Ademuyiwa
JLJean Wilguens Lartigue
Jean Wilguens Lartigue
Early death after cancer surgery is higher in low-income and middle-income countries (LMICs) compared with in high-income countries, yet the impact of facility characteristics on early postoperative outcomes is unknown. The aim of this study was to examine the association between hospital infrastructure, resource availability, and processes on early outcomes after cancer surgery worldwide. A multimethods analysis was performed as part of the GlobalSurg 3 study—a multicentre, international, prospective cohort study of patients who had surgery for breast, colorectal, or gastric cancer. The primary outcomes were 30-day mortality and 30-day major complication rates. Potentially beneficial hospital facilities were identified by variable selection to select those associated with 30-day mortality. Adjusted outcomes were determined using generalised estimating equations to account for patient characteristics and country-income group, with population stratification by hospital. Between April 1, 2018, and April 23, 2019, facility-level data were collected for 9685 patients across 238 hospitals in 66 countries (91 hospitals in 20 high-income countries; 57 hospitals in 19 upper-middle-income countries; and 90 hospitals in 27 low-income to lower-middle-income countries). The availability of five hospital facilities was inversely associated with mortality: ultrasound, CT scanner, critical care unit, opioid analgesia, and oncologist. After adjustment for case-mix and country income group, hospitals with three or fewer of these facilities (62 hospitals, 1294 patients) had higher mortality compared with those with four or five (adjusted odds ratio [OR] 3·85 [95% CI 2·58–5·75]; p<0·0001), with excess mortality predominantly explained by a limited capacity to rescue following the development of major complications (63·0% vs 82·7%; OR 0·35 [0·23–0·53]; p<0·0001). Across LMICs, improvements in hospital facilities would prevent one to three deaths for every 100 patients undergoing surgery for cancer. Hospitals with higher levels of infrastructure and resources have better outcomes after cancer surgery, independent of country income. Without urgent strengthening of hospital infrastructure and resources, the reductions in cancer-associated mortality associated with improved access will not be realised. National Institute for Health and Care Research.

13 November 2017 in Annals of Surgical Oncology
Verified
Journal Article
Closed access
PDF file
APOSTOLOS GAITANIDISAPOSTOLOS GAITANIDIS
APOSTOLOS GAITANIDIS
DPDhaval T. Patel
Dhaval T. Patel
NNNaris Nilubol
Naris Nilubol
ATAmit Tirosh
Amit Tirosh
SSSamira Sadowski
Samira Sadowski
EKElectron Kebebew
Electron Kebebew

1 January 2018 in Surgery
Verified
Journal Article
Closed access
PNPavel Nockel
Pavel Nockel
MLMustapha El Lakis
Mustapha El Lakis
APOSTOLOS GAITANIDISAPOSTOLOS GAITANIDIS
APOSTOLOS GAITANIDIS
LYLily Yang
Lily Yang
RMRoxanne Merkel
Roxanne Merkel
EKElectron Kebebew
Electron Kebebew